3-((3-(2-carboxyethyl)-4-methylpyrrol-2-yl)methylene)-2-inolinone,
SU 5402,
Su-5402,
SU5402,
su5402,
215543-92-3,
SU 5402,
SU-5402,
3-[3-(2-Carboxyethyl)-4-methylpyrrol-2-methylidenyl]-2-indolinone,
(Z)-3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid,
CHEMBL89363,
3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,
J-502595,
3-{[3-(2-carboxyethyl)-4-methylpyrrol-2-yl]methylene}-2-indolinone,
(Z)-3-(4-Methyl-2-((2-oxoindolin-3-ylidene)-methyl)-1H-pyrrol-3-yl)propanoic acid,
3-[4-methyl-2-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid,
3-{4-methyl-2-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid,
2-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrole-3-propanoic acid,
CHEBI:63449,
PubChem22440,
AC1NRD9M,
KDR Kinase Inhibitor, 5,
MLS006010689,
SCHEMBL177917,
BDBM4882,
DTXSID90415361,
SYN1084,
3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid,
BCPP000060,
ZINC3815485,
ABP000876,
RS0048,
AKOS015994575,
CS-0200,
DB08577,
ES-0043,
QC-8974,
SU-5402/SU5402/,
AJ-45705,
HY-10407,
SMR004701670,
AB0035835,
Y0244,
SU-5402, >=98% (HPLC),
W-5368,
(Z)-3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-yl)methylidenyl]indolin-2-one,
3-(4-methyl-2-{[(3Z)-2-oxo-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid,
3-(4-methyl-2-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid,
3-{4-methyl-2-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid,
D0A4XJ,
cc-522,
JNDVEAXZWJIOKB-JYRVWZFOSA-N,
C17H16N2O3,
CID5289418,
A11558,
C105686,
3-((3-(2-carboxyethyl)-4-methylpyrrol-2-yl)methylene)-2-inolinone,
3-(4-METHYL-2-((Z)-(2-OXOINDOLIN-3-YLIDENE)METHYL)-1H-PYRROL-3-YL)PROPANOIC ACID,
SU1,